semaglutide and cardiovascular outcomes in diabetes risk #VisualAbstract: Obesity without New Science Suggests Semaglutide Improves – Anti-Obesity Drugs, Lifestyle Interventions Show

I wrote all about Anti-Spike here, and just to repeat what I said about Eriomin in that case, there are two studies about this citrus extract and blood glucose

GLP-1 drugs linked to reduced risk of epilepsy A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy

Both medications represent the cutting edge of obesity and diabetes treatment, but they're at different stages of availability

The authors concluded that pretreating with hydrogen gas protects against CIH-caused liver injury, demonstrating its efficacy in reducing oxidative stress and protecting liver cells from injury caused by chronic intermittent hypoxic exposure

At 5 mg/mL (most common), 0.25 mg equals 5 units, 1 mg equals 20 units, and 2.4 mg equals 48 units